MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

GSK

  • Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market
    Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market
    GSK plans to sell generic versions of the inhalers, but many are still worried about insurance coverage for alternatives.
    December 29, 2023BY Naveen Athrappully
  • FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
    FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
    A committee of outside advisers to the U.S. Food and Drug Administration (FDA) recommended a vaccine from GlaxoSmithKline (GSK) ...
    March 2, 2023BY Mimi Nguyen Ly
  • GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback
    GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback
    Britain's GSK said on Friday it would limit the use of its ovarian cancer drug Zejula in the ...
    November 11, 2022BY Reuters
  • GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK's blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was ...
    November 7, 2022BY Reuters
  • GSK Says FDA Approves Kidney Disease Drug for Children
    GSK Says FDA Approves Kidney Disease Drug for Children
    GSK Plc. said on Wednesday the Food and Drug Administration (FDA) had cleared its kidney disease drug Benlysta ...
    July 29, 2022BY Reuters
  • Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off
    Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off
    LONDON—Pfizer plans to exit its 32 percent stake in Haleon, a consumer health joint venture with British drugmaker ...
    June 1, 2022BY Reuters
  • GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead
    GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead
    Britain's GlaxoSmithKline will receive $1.25 billion from Gilead Sciences as part of a settlement between its HIV medicines ...
    February 3, 2022BY Reuters
  • GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets
    GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets
    GlaxoSmithKline on Saturday said it had rejected a 50-billion-pound offer from Unilever for its consumer goods arm, saying ...
    January 18, 2022BY Reuters
  • Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO
    Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO
    The head of a medical supplies company involved in the distribution and supply of monoclonal antibodies across southeastern ...
    January 13, 2022BY Tammy Hung
  • GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi
    GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi
    GlaxoSmithKline PLC (GSK) said on Tuesday it would develop an HIV treatment with Japan's Shionogi for use in ...
    September 28, 2021BY Reuters
  • EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    BRUSSELS—The European Union has signed a contract with GlaxoSmithKline (GSK) for the supply of up to 220,000 treatments ...
    July 28, 2021BY Reuters
  • Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK
    Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK
    Swiss authorities have agreed to extradite a Chinese researcher to the United States, where he is accused of ...
    July 17, 2019BY Frank Fang
  • Drugmaker GSK to Eliminate 650 US Jobs
    Drugmaker GSK to Eliminate 650 US Jobs
    British drugmaker GlaxoSmithKline Plc said on Sept. 5 it would cut about 650 positions in the United States ...
    September 5, 2018BY Reuters
  • British Private Eye in China Prosecuted for Knowing Too Much
    British Private Eye in China Prosecuted for Knowing Too Much
    A British private investigator and his Chinese-American wife are being prosecuted in Shanghai, ostensibly for obtaining private information ...
    July 14, 2014BY Matthew Robertson
TOP NEWS
  • Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
    1hr By Jack Phillips
    Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    2hr By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    3hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    4hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing–How to Enhance Its Function
    4hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing–How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    8hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
  • US Bankruptcy Filings Increase 7 Percent Yearly
    9hr By Naveen Athrappully
    US Bankruptcy Filings Increase 7 Percent Yearly
  • How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
    10hr By Jacob Burg
    How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
  • Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
    16hr By Melanie Sun
    Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
  • Kentucky Derby Champion Golden Tempo Wins 2026 Belmont Stakes
    18hr By Ross Kelly
    Kentucky Derby Champion Golden Tempo Wins 2026 Belmont Stakes
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top